https://clinicaltrials.gov/ct2/show/NCT03710707?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F22%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Study to Evaluate DNL201 in Subjects With Parkinson’s Disease
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: DNL201 low dose; Drug: DNL201 high dose; Drug: Placebo
Sponsor: Denali Therapeutics Inc.
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03710707
FIRST POSTED:
Thu, 18 Oct 2018 12:00:00 EDT
LAST UPDATE POSTED:
06/05/19 07:44AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03710707?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F22%2F2019&lupd_d=14&sort=nwst